Martin Faehling

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.

Martin Faehling, Sabine Fallscheer, Birgit Schwenk

|Aug 01, 2018
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.

Martin Faehling, Birgit Schwenk, Sebastian Kramberg

|Apr 25, 2018
Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).

M Faehling, J Achenbach, P Staib

Pageof 1